Abstract
Malignant melanoma is known to display a tremendous histologic diversity. Expe-rience has shown that biomarkers determined in research laboratories can be adapted to everyday histopathology routine. However, the present immunohistochemical markers are not applicable for differentiation between malignant melanoma and melanocytic borderline lesions mimicking melanoma, such as dysplastic nevus, Spitz nevus or deep penetrating nevus (Roesch et al. 2006a). Thus, we intended to discriminate true malignant tumor progression from invasive, but non-metastasizing melanocytic growth applying our recently established algorithm for immunohistochemical marker evaluation (Roesch et al. 2005a, b, 2006b). This new approach could be helpful for further studies, because it allows straightforward and exact histo-morphologic assessment of candidate markers.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdel-Ghany, M., Cheng, H., Levine, R.A., and Pauli, B.U. (1998) Truncated dipeptidyl peptidase IV is a potent anti-adhesion and anti-metastasis peptide for rat breast cancer cells. Invasion. Metastasis. 18:35–43
Airola, K., Karonen, T., Vaalamo, M., Lehti, K., Lohi, J., Kariniemi, A.L., Keski-Oja, J., Saarialho-Kere UK (1999) Expression of collagenases-1 and -3 and their inhibitors TIMP-1 and -3 correlates with the level of invasion in malignant melanomas. Br. J. Cancer. 80:733–743
Barnhill, R.L., Barnhill, M.A., Berwick, M., and Mihm, M.C. Jr (1991a) The histologic spectrum of pigmented spindle cell nevus: a review of 120 cases with emphasis on atypical variants. Hum. Pathol. 22:52–58
Barnhill, R.L., Mihm, M.C. Jr and Magro, C.M. (1991b) Plexiform spindle cell naevus: a distinctive variant of plexiform melanocytic naevus. Histopathology 18:243–247
Hofmann, U.B., Westphal, J.R., Van Muijen, G.N., and Ruiter, D.J. (2000a) Matrix metalloproteinases in human melanoma. J. Invest. Dermatol. 115:337–344
Hofmann, U.B., Westphal, J.R., Zendman, A.J., Becker, J.C., Ruiter, D.J., and van Muijen, G.N. (2000b) Expression and activation of matrix metalloproteinase-2 (MMP-2) and its co-localization with membrane-type 1 matrix metalloproteinase (MT1-MMP) correlate with melanoma progression. J. Pathol. 191:245–256
Houghton, A.N., Albino, A.P., Cordon-Cardo, C., Davis, L.J., and Eisinger, M. (1988) Cell surface antigens of human melanocytes and melanoma. Expression of adenosine deaminase binding protein is extinguished with melanocyte transformation. J. Exp. Med. 167:197–212
Kajiyama, H., Kikkawa, F., Khin, E., Shibata, K., Ino, K., and Mizutani, S. (2003) Dipeptidyl peptidase IV overexpression induces up-regulation of E-cadherin and tissue inhibitors of matrix metalloproteinases., resulting in decreased invasive potential in ovarian carcinoma cells. Cancer. Res. 63:2278–2283
Mehregan, D.A., and Mehregan, A.H. (1993) Deep penetrating nevus. Arch. Dermatol. 129:328–331
Mehregan, D.R., Mehregan, D.A., and Mehregan, A.H. (1995) Proliferating cell nuclear antigen staining in deep-penetrating nevi. J. Am. Acad. Dermatol. 33:685–687
Morrison, M.E., Vijayasaradhi, S., Engelstein, D., Albino, A.P., and Houghton, A.N. (1993) A marker for neoplastic progression of human melanocytes is a cell surface ectopeptidase. J. Exp. Med. 177:1135–1143
Pethiyagoda, C.L., Welch, D.R., and Fleming, T.P. (2000) Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells. Clin. Exp. Metastasis. 18:391–400
Pro, B., and Dang, N.H. (2004) CD26/dipeptidyl peptidase IV. and its role. in cancer. Histol. Histopathol. 19:1345–1351
Robson, A., Morley-Quante, M., Hempel, H., McKee, P.H., and Calonje, E. (2003) Deep penetrating naevus: clinicopathological study of 31 cases with further delineation of histological features allowing distinction from other pigmented benign melanocytic lesions and melanoma. Histopathology 43:529–537
Roesch, A., Becker, B., Meyer, S., Hafner, C., Wild, P.J., Landthaler, M., and Vogt, T. (2005a) Overexpression and hyperphosphorylation of retinoblastoma protein in the progression of malignant melanoma. Mod. Pathol. 18:565–572
Roesch, A., Becker, B., Meyer, S., Wild, P., Hafner, C., Landthaler, M., and Vogt, T. (2005b) Retinoblastoma-binding protein 2-homolog 1: a retinoblastoma-binding protein downregulated in malignant melanomas. Mod. Pathol. 18:1249–1257
Roesch, A., Burgdorf, W., Stolz, W., Landthaler, M., and Vogt, T. (2006a) Dermatoscopy of “dysplastic nevi”: a beacon in diagnostic darkness. Eur. J. Dermatol. 16:479–493
Roesch, A., Wittschier, S., Becker, B., Landthaler, M., and Vogt, T. (2006b) Loss of dipeptidyl peptidase IV immunostaining discriminates malignant melanomas from deep penetrating nevi. Mod. Pathol. 19:1378–1385
Ruiter, D.J., van Dijk, M.C., and Ferrier, C.M. (2003) Current diagnostic problems in melanoma pathology. Semin. Cutan. Med. Surg. 22:33–41
Seab, J.A. Jr, Graham, J.H., and Helwig, E.B. (1989) Deep penetrating nevus. Am. J. Surg. Pathol. 13:39–44
Skelton HG 3rd, Smith, K.J., Barrett, T.L., Lupton, G.P., and Graham, J.H. (1991) HMB-45 staining in benign. and malignant melanocytic. lesions. A reflection of cellular activation. Am. J. Dermatopathol. 13:543–550
Vaisanen, A., Tuominen, H., Kallioinen, M., Turpeenniemi-Hujanen T (1996) Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression. and may have. prognostic value. J. Pathol. 180:283–289
Vaisanen, A., Kallioinen, M., Taskinen, P.J., Turpeenniemi-Hujanen T (1998) Prognostic value of MMP-2 immunoreactive protein (72 kD type IV collagenase) in primary skin melanoma. J. Pathol. 186:51–58
Wesley, U.V., Albino, A.P., Tiwari, S., and Houghton, A.N. (1999) A role for dipeptidyl peptidase IV in suppressing the malignant phenotype of melanocytic cells. J. Exp. Med. 190:311–322
Wesley, U.V., McGroarty, M., and Homoyouni, A. (2005) Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway. Cancer. Res. 65:1325–1334
Yang, Y., Dang, D., Atakilit, A., Schmidt, B., Regezi, J., Li, X., Eisele, D., Ellis, D., and Ramos, D.M. (2003) Specific alpha v integrin receptors modulate K1735 murine melanoma cell behavior. Biochem. Biophys. Res. Commun. 308:814–819
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media B.V.
About this chapter
Cite this chapter
Roesch, A., Landthaler, M., Vogt, T. (2010). Malignant Melanoma Versus Deep Penetrating Nevus: Diagnostic and Prognostic Immunohistochemistry of Dipeptidyl Peptidase IV (Methodology). In: Hayat, M. (eds) Methods of Cancer Diagnosis, Therapy, and Prognosis. Methods of Cancer Diagnosis, Therapy and Prognosis, vol 6. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-2918-8_27
Download citation
DOI: https://doi.org/10.1007/978-90-481-2918-8_27
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-90-481-2917-1
Online ISBN: 978-90-481-2918-8
eBook Packages: MedicineMedicine (R0)